Hims & Hers Health
Stock Forecast, Prediction & Price Target
Hims & Hers Health (HIMS) stock Price Target by analysts
$26.29
Potential downside: -37.14%
Hims & Hers Health price prediction
What is Hims & Hers Health stock analysts` prediction?
Hims & Hers Health stock forecast: Based on 6 Wall Street analysts` predicted price targets for Hims & Hers Health in the last 3 months, the avarage price target is $26.29, with a high forecast of $NaN. The average price target represents a -37.14% change from the last price of $41.82.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Hims & Hers Health stock Price Target by analysts
Full breakdown of analysts given Hims & Hers Health price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Maria Ripps Canaccord Genuity | 0% 0/3 | 10 months ago | $38 -9.13% downside | $30.81 | StreetInsider | Previous targets (2) |
Korinne Wolfmeyer Piper Sandler | 0% 0/2 | 11 months ago | $21 -49.78% downside | $20.64 | StreetInsider | Previous targets (1) |
Ryan MacDonald Needham | 0% 0/1 | 11 months ago | $28 -33.04% downside | $20.96 | StreetInsider | Previous targets (0) |
Michael Cherny Leerink Partners | 0% 0/1 | 11 months ago | $26 -37.83% downside | $23.08 | StreetInsider | Previous targets (0) |
Michael Cherny Bank of America Securities | 0% 0/2 | 11 months ago | $25 -40.22% downside | $22.15 | StreetInsider | Previous targets (1) |
Jailendra Singh Truist Financial | 0% 0/2 | 12 months ago | $23 -45.00% downside | $19.83 | StreetInsider | Previous targets (1) |
Michael Cherny Bank of America Securities | 0% 0/2 | 12 months ago | $23 -45.00% downside | $19.83 | StreetInsider | Previous targets (1) |
Allen Lutz Bank of America Securities | 0% 0/1 | about 1 year ago | $20 -52.17% downside | $15.82 | TheFly | Previous targets (0) |
Daniel Grosslight Citigroup | 0% 0/1 | about 1 year ago | $20 -52.17% downside | $14.93 | StreetInsider | Previous targets (0) |
Glen Santangelo Jefferies | 0% 0/3 | about 1 year ago | $18 -56.96% downside | $16.04 | StreetInsider | Previous targets (2) |
George Hill Deutsche Bank | 0% 0/2 | about 1 year ago | $23 -45.00% downside | $16.88 | StreetInsider | Previous targets (1) |
Maria Ripps Canaccord Genuity | 0% 0/3 | over 1 year ago | $24 -42.61% downside | $17.56 | StreetInsider | Previous targets (2) |
Glen Santangelo Jefferies | 0% 0/3 | over 1 year ago | $14 -66.52% downside | $12.35 | StreetInsider | Previous targets (2) |
George Hill Deutsche Bank | 0% 0/2 | over 1 year ago | $16 -61.74% downside | $11.65 | StreetInsider | Previous targets (1) |
Korinne Wolfmeyer Piper Sandler | 0% 0/2 | over 1 year ago | $13 -68.91% downside | $12.39 | StreetInsider | Previous targets (1) |
Jailendra Singh Truist Financial | 0% 0/2 | over 1 year ago | $13 -68.91% downside | $12.41 | Benzinga | Previous targets (1) |
Glen Santangelo Jefferies | 0% 0/3 | over 1 year ago | $15 -64.13% downside | $13.22 | StreetInsider | Previous targets (2) |
Maria Ripps Canaccord Genuity | 0% 0/3 | over 1 year ago | $20 -52.17% downside | $14.55 | StreetInsider | Previous targets (2) |
Unknown Credit Suisse | N/A | about 3 years ago | $8 -80.87% downside | $6.57 | Benzinga | N/A |
Unknown Leerink Partners | N/A | about 3 years ago | $5 -88.04% downside | $6.71 | Benzinga | N/A |
Unknown Piper Sandler | N/A | over 3 years ago | $6 -85.65% downside | $3.59 | Benzinga | N/A |
Hims & Hers Health Financial Estimates
Hims & Hers Health Revenue Estimates
Hims & Hers Health EBITDA Estimates
Hims & Hers Health Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $271.87M N/A | $526.91M 93.80% | $872M 65.49% | Avg: $1.58B Low: $1.41B High: $1.96B avg. 81.59% | Avg: $1.89B Low: $1.79B High: $2.18B avg. 19.84% | Avg: $2.22B Low: $2.10B High: $2.55B avg. 17.08% | Avg: $2.25B Low: $2.13B High: $2.59B avg. 1.37% |
Net Income
% change YoY
| $-107.65M N/A | $-65.67M 38.99% | $-23.54M 64.14% | Avg: $72.28M Low: $37.68M High: $117.23M avg. 407.01% | Avg: $108.53M Low: $64.89M High: $133.98M avg. 50.13% | Avg: $195.38M Low: $181.72M High: $233.52M avg. 80.02% | Avg: $217.71M Low: $202.49M High: $260.21M avg. 11.42% |
EBITDA
% change YoY
| $-110.52M N/A | $-61.22M 44.60% | $-19.93M 67.43% | Avg: $-487.60M Low: $-606.53M High: $-437.06M avg. -2345.62% | Avg: $-584.39M Low: $-672.13M High: $-552.96M avg. -19.84% | Avg: $-684.22M Low: $-786.95M High: $-647.42M avg. -17.08% | Avg: $-693.62M Low: $-797.76M High: $-656.32M avg. -1.37% |
EPS
% change YoY
| -$0.58 N/A | -$0.32 44.82% | -$0.11 65.62% | Avg: $0.33 Low: $0.18 High: $0.56 avg. 399.51% | Avg: $0.47 Low: $0.31 High: $0.64 avg. 43.66% | Avg: $0.93 Low: $0.87 High: $1.12 avg. 97.18% | Avg: $1.04 Low: $0.97 High: $1.24 avg. 11.42% |
Operating Expenses
% change YoY
| $319.53M N/A | $477.41M 49.41% | $744.40M 55.92% | Avg: $1.58B Low: $1.42B High: $1.97B avg. 112.96% | Avg: $1.89B Low: $1.79B High: $2.18B avg. 19.84% | Avg: $2.22B Low: $2.10B High: $2.55B avg. 17.08% | Avg: $2.25B Low: $2.13B High: $2.59B avg. 1.37% |
FAQ
What is Hims & Hers Health stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 137.15% in 2025-2028.
We have gathered data from 9 analysts. Their low estimate is 37.68M, average is 72.28M and high is 117.23M.
What is Hims & Hers Health stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 29.97% in 2025-2028.
We have gathered data from 11 analysts. Their low revenue estimate is $1.41B, average is $1.58B and high is $1.96B.
What is Hims & Hers Health stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 137.94% in 2025-2028.
We have gathered data from 9 analysts. Their low earnings per share estimate is $0.18, average is $0.33 and high is $0.56.
What is the best performing analyst?
In the last twelve months 6 analysts have been covering Hims & Hers Health stock. The most successful analyst is Maria Ripps.